Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
CC transcript
AUXILIUM PHARMACEUTICALS INC (AUXL) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/30/2014 8-K Quarterly results
Docs: "AUXILIUM PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER 2014 FINANCIAL RESULTS"
08/07/2014 8-K Quarterly results
Docs: "AUXILIUM PHARMACEUTICALS, INC. ANNOUNCES SECOND QUARTER 2014 FINANCIAL RESULTS"
11/06/2013 8-K Quarterly results
Docs: "AUXILIUM PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER 2013 FINANCIAL RESULTS - 3Q13 Total Net Revenues Increased by 52% vs. 3Q12 to $108.1 MM -"
08/01/2013 8-K Investor presentation, Quarterly results
Docs: "AUXILIUM PHARMACEUTICALS, INC, ANNOUNCES SECOND QUARTER 2013",
"Second Quarter 2013 Earnings Call Presentation Materials"
02/26/2013 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results and Guidance for 2013 - 2012 Marks First Full Year of Profitability - - 2013 Net Revenues Expected to be in the Range of $325 Million to $355 Million -"
11/07/2012 8-K Quarterly results
Docs: "Amendment No. 1 to the Development, Commercialization and Supply Agreement, by and among, Auxilium Pharmaceuticals, Inc., Auxilium International Holdings, Inc. and Pfizer Inc",
"AUXILIUM PHARMACEUTICALS, INC. ANNOUNCES THIRD QUARTER 2012 FINANCIAL RESULTS -3Q12 Total Net Revenues Increased by 6% vs. 3Q11 to $71.0 MM - -2012 Guidance Revised -",
"PFIZER CONTACTS: For Media: For Investors: Joan Campion : 212.733.2798 Suzanne Harnett: 733-8009 [email protected] [email protected] ###",
"AUXILIUM PHARMACEUTICALS, INC. SUBMITS SUPPLEMENTAL BIOLOGICS LICENSE APPLICATION TO THE FDA FOR XIAFLEX® FOR THE TREATMENT OF PEYRONIE'S DISEASE"
07/31/2012 8-K Form 8-K - Current report
02/23/2012 8-K Quarterly results
Docs: "AUXILIUM PHARMACEUTICALS, INC, ANNOUNCES FOURTH QUARTER AND FULL YEAR 2011 FINANCIAL RESULTS AND GUIDANCE FOR 2012 - 2011 Net Revenues Increased by 25% to a record $264.3 Million - - 2012 Net Revenues Expected to be in the Range of $283 Million to $305 Million -"
10/31/2011 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results and Recent Operational Highlights"
08/01/2011 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results and Recent Operational Highlights"
05/09/2011 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces First Quarter 2011 Financial Results and Operational Highlights"
02/10/2011 8-K Form 8-K - Current report
11/04/2010 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2010 Financial Results and Operational Highlights"
08/05/2010 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2010 Financial Results and Operational Highlights"
05/03/2010 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results and Operational Highlights"
02/17/2010 8-K Form 8-K - Current report
10/28/2009 8-K Form 8-K - Current report
08/06/2009 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results and Operational Highlights"
05/06/2009 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces First Quarter 2009 Financial Results and Operational Highlights"
02/18/2009 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results, as well as Guidance for 2009"
10/29/2008 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2008 Financial Results and Operational Highlights"
07/31/2008 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2008 Financial Results and Operational Highlights"
04/30/2008 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces First Quarter 2008 Financial Results and Operational Highlights"
02/14/2008 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2007 Financial Results, as well as Guidance for 2008"
10/31/2007 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results and Operational Highlights"
07/31/2007 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2007 Financial Results and Operational Highlights"
05/01/2007 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces First Quarter 2007 Financial Results and Operational Highlights"
02/15/2007 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2006 Financial Results, as well as Guidance for 2007 Full Year 2006 Net Revenues Increase by 60% to $68.5 Million 2007 Net Revenues Expected to be in the Range of $88 Million to $92 Million"
10/31/2006 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Third Quarter 2006 Financial Results Q3 Net Revenues Up 57% versus Q3 of 2005"
08/02/2006 8-K Quarterly results
Docs: "Auxilium Pharmaceuticals, Inc. Announces Second Quarter 2006 Financial Results Q2 Net Revenues Up 67% versus Q2 of 2005"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy